| Literature DB >> 26679759 |
Faraz Hussain, Christopher J Langmead, Qi Mi, Joyeeta Dutta-Moscato, Yoram Vodovotz, Sumit K Jha.
Abstract
BACKGROUND: Probabilistic models have gained widespread acceptance in the systems biology community as a useful way to represent complex biological systems. Such models are developed using existing knowledge of the structure and dynamics of the system, experimental observations, and inferences drawn from statistical analysis of empirical data. A key bottleneck in building such models is that some system variables cannot be measured experimentally. These variables are incorporated into the model as numerical parameters. Determining values of these parameters that justify existing experiments and provide reliable predictions when model simulations are performed is a key research problem.Entities:
Mesh:
Year: 2015 PMID: 26679759 PMCID: PMC4674867 DOI: 10.1186/1471-2105-16-S17-S8
Source DB: PubMed Journal: BMC Bioinformatics ISSN: 1471-2105 Impact factor: 3.169
Figure 1Comparison of the efficiency of (a) Bayesian and (b) SPRT hypothesis testing. In both cases, the number of samples required for hypothesis testing increases as the specification threshold probability approaches the actual probability with which the model satisfies the specification. Bayesian hypothesis testing required fewer samples than the SPRT when the model is obviously flawed with respect to the desired behavior. The number of samples for the Bayesian hypothesis testing vary from 1 to 1000 while those for the SPRT become as large as 100000.
Parameters of the acute inflammatory response model synthesized by our algorithm.
| param. 1 (LPS-evap) | 0.932575 |
| param. 2 (mac-act-LPS) | 0.661416 |
| param. 3 (mac-act-pro) | 0.326682 |
| param. 4 (mac-regen) | 12.655 |
| param. 5 (mac-age) | 60.5967 |
| param. 6 (mac-act-dam) | 0.3916 |
| param. 7 (max-pro-dam) | 18.5986 |
| param. 8 (pro-dam-thresh) | 0.51023 |
| param. 9 (damage-evap) | 0.276594 |
| param. 10 (anti-heal-thresh) | 7.92487 |
| param. 11 (mac-anti) | 0.442621 |
| param. 12 (anti-evap) | 0.623503 |
| param. 13 (pro-evap) | 0.142298 |
| param. 14 (mac-prop) | 8.39519 |
| param. 15 (exp1-dose-time) | 149.574 |
| param. 16 (exp1-dose-duration) | 4.80575 |
| param. 17 (exp1-dose-amount) | 3352.54 |
| param. 18 (exp2-dose-time) | 467.262 |
| param. 19 (exp2-dose-duration) | 458.451 |
| param. 20 (exp2-dose-amount) | 896067 |
| param. 21 (exp3-1st-dose-time) | 33.3838 |
| param. 22 (exp3-2nd-dose-time) | 407.352 |
| param. 23 (exp3-doses-duration) | 41.6759 |
| param. 24 (exp3-doses-amount) | 2628.97 |
| param. 25 (exp4-1st-dose-time) | 8.24293 |
| param. 26 (exp4-2nd-dose-time) | 411.959 |
| param. 27 (exp4-doses-duration) | 4.40842 |
| param. 28 (exp4-doses-amount) | 4494.65 |
Figure 2Parallel simulations showing SPARK output for 10 threads. Figures (a), (b), (c), and (d) show traces for the activated phagocyte count over time on invocation of the ABM simulator. Satisfaction of the four specifications was determined by a monitoring script that checks traces for each of the desired behaviors. One can visually verify that the ABM parameterized with the values in Table 1 satisfies all the four expert-provided specifications.